What if the key to beating the most common type of breast cancer lay hidden in the body's own defenses, waiting for science to unlock its potential? For the millions of women diagnosed with estrogen receptor-positive (ER-positive) breast cancer, which accounts for about 70% of all cases, a new
What happens when the very architects of public health safety turn against their own system, warning of a dangerous shift that could jeopardize millions of lives? Twelve former FDA commissioners, a powerhouse of regulatory wisdom, have ignited a firestorm by publicly condemning proposed changes to
Diving into the mysteries of the human brain, I’m thrilled to sit down with a leading expert in neuroscience whose groundbreaking work has reshaped our understanding of brain plasticity and adult neurogenesis. As a full professor at the University of Amsterdam and head of the Brain Plasticity
What if a remedy hailed as a breakthrough for countless ailments turns out to be more myth than medicine? Across the U.S. and Canada, millions have turned to medical cannabis, hoping for relief from chronic pain, anxiety, and more. Yet, beneath the buzz, a sobering reality emerges: scientific
What if the complex journey of turning a groundbreaking biologic into a life-saving therapy could be transformed into a streamlined, efficient process? In a world where biopharmaceutical development faces unprecedented challenges, a powerful collaboration between Rentschler Biopharma and Coriolis
Imagine a simple shot, one already familiar to millions for preventing a painful skin condition, holding the power to shield the mind from a devastating disease like dementia—a condition impacting over 55 million people worldwide with no cure in sight. That’s the startling promise emerging from a
